Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Herman Tournaye

Showing results (231-240 of 268) with videos related to

Pageof 27
Sort By:
Environment International|August 21, 2015
Human exposure to endocrine disrupting chemicals and fertility: A case-control study in male subfertility patientsElly Den Hond, Herman Tournaye, Petra De Sutter, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|July 15, 2015
Corifollitropin alfa followed by hpHMG in GnRH agonist protocols. Two prospective feasibility studies in poor ovarian respondersNikolaos P Polyzos, Roberta Corona, Arne Van De Vijver, et al.
Frontiers in Endocrinology|May 20, 2020
Impact of Serum Estradiol Levels Prior to Progesterone Administration in Artificially Prepared Frozen Embryo Transfer CyclesShari Mackens, Samuel Santos-Ribeiro, Ellen Orinx, et al.
Human Reproduction (Oxford, England)|October 11, 2018
Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trialGeorg Griesinger, Christophe Blockeel, Gennady T Sukhikh, et al.
Human Reproduction (Oxford, England)|September 20, 2020
Outcome of in-vitro oocyte maturation in patients with PCOS: does phenotype have an impact?Shari Mackens, Stéphanie Pareyn, Panagiotis Drakopoulos, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|July 15, 2015
Everolimus, an mTOR pathway inhibitor, is highly successful on ovarian hyperstimulation syndrome by reducing ovarian weight and progesterone levels: a preclinical experimental randomized controlled studyIoannis P Kosmas, Chrysoula Kitsou, Leandros Lazaros, et al.
Reproductive Biomedicine Online|May 30, 2020
The performance of the Elecsys® anti-Müllerian hormone assay in predicting extremes of ovarian response to corifollitropin alfaAna Raquel Neves, Christophe Blockeel, Georg Griesinger, et al.
Human Reproduction (Oxford, England)|September 23, 2020
The freeze-all strategy versus agonist triggering with low-dose hCG for luteal phase support in IVF/ICSI for high responders: a randomized controlled trialSamuel Santos-Ribeiro, Shari Mackens, Biljana Popovic-Todorovic, et al.
Reproductive Biomedicine Online|May 2, 2023
Association between sequence variants in the FSHR gene and reproductive outcomes following IVF in predicted normorespondersAna Raquel Neves, Sandra Garcia, Lan Tn Vuong, et al.
Human Molecular Genetics|March 14, 2022
Mitochondrial DNA variants segregate during human preimplantation development into genetically different cell lineages that are maintained postnatallyJoke Mertens, Marius Regin, Neelke De Munck, et al.
Pageof 27

Showing results (231-240 of 268) with videos related to

Sort By:
Pageof 27
Environment International|August 21, 2015
Human exposure to endocrine disrupting chemicals and fertility: A case-control study in male subfertility patientsElly Den Hond, Herman Tournaye, Petra De Sutter, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|July 15, 2015
Corifollitropin alfa followed by hpHMG in GnRH agonist protocols. Two prospective feasibility studies in poor ovarian respondersNikolaos P Polyzos, Roberta Corona, Arne Van De Vijver, et al.
Frontiers in Endocrinology|May 20, 2020
Impact of Serum Estradiol Levels Prior to Progesterone Administration in Artificially Prepared Frozen Embryo Transfer CyclesShari Mackens, Samuel Santos-Ribeiro, Ellen Orinx, et al.
Human Reproduction (Oxford, England)|October 11, 2018
Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trialGeorg Griesinger, Christophe Blockeel, Gennady T Sukhikh, et al.
Human Reproduction (Oxford, England)|September 20, 2020
Outcome of in-vitro oocyte maturation in patients with PCOS: does phenotype have an impact?Shari Mackens, Stéphanie Pareyn, Panagiotis Drakopoulos, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|July 15, 2015
Everolimus, an mTOR pathway inhibitor, is highly successful on ovarian hyperstimulation syndrome by reducing ovarian weight and progesterone levels: a preclinical experimental randomized controlled studyIoannis P Kosmas, Chrysoula Kitsou, Leandros Lazaros, et al.
Reproductive Biomedicine Online|May 30, 2020
The performance of the Elecsys® anti-Müllerian hormone assay in predicting extremes of ovarian response to corifollitropin alfaAna Raquel Neves, Christophe Blockeel, Georg Griesinger, et al.
Human Reproduction (Oxford, England)|September 23, 2020
The freeze-all strategy versus agonist triggering with low-dose hCG for luteal phase support in IVF/ICSI for high responders: a randomized controlled trialSamuel Santos-Ribeiro, Shari Mackens, Biljana Popovic-Todorovic, et al.
Reproductive Biomedicine Online|May 2, 2023
Association between sequence variants in the FSHR gene and reproductive outcomes following IVF in predicted normorespondersAna Raquel Neves, Sandra Garcia, Lan Tn Vuong, et al.
Human Molecular Genetics|March 14, 2022
Mitochondrial DNA variants segregate during human preimplantation development into genetically different cell lineages that are maintained postnatallyJoke Mertens, Marius Regin, Neelke De Munck, et al.
Pageof 27